Synergistic effect of a noval oxymatrine-baicalin combination against hepatitis B virus replication, α smooth muscle actin expression and type I collagen synthesis in vitro

World Journal of Gastroenterology

Volumn 12, Issue 32, 2006, Pages 5153-5159

  Cheng, Yang ^a   Ping, Jian ^a   Xu, Huai Dong ^b   Fu, Hai Jun ^b   Zhou, Zhao Hui ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Kairuisi Biotechnological Co Ltd   (China)

Author keywords

2.2.15 cells; Baicalin; Hepatitis B virus; HSC T6 cells; Oxymatrine; Type I collagen; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BAICALIN; BETA ACTIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; OXYMATRINE; PYROXYLIN; VIRUS DNA; ACTIN; ALKALOID; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; FLAVONOID;

ANIMAL CELL; ARTICLE; CELL LINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION; SUPERNATANT; VIRUS REPLICATION; BIOSYNTHESIS; DRUG COMBINATION; DRUG EFFECT; LIVER; METABOLISM; VIROLOGY;

ACTINS; ALKALOIDS; ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; COLLAGEN TYPE I; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER;

EID: 33748479265     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K. Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection. J Gastroenterol Hepatol 2005; 20: 1726-1730
2. Cheng Y, Zhang M, Liu C, Wu X, Zhang Q. Effect of Oxymatrine on collagen synthesis and expression of TGF-β1 in an immune hepatic fibrosis model. Zhongxiyi Jiehe Ganbing Zazhi 2001; 11: 210-212
3. Cheng Y, Zhang M, Li H, Wu X, Zhang Q. Study on the mechanism of oxymatrine on immune hepatic fibrosis by Concanavalin A in BALB/c mice. Xiandai Shiyong Yixue 2001; 13: 14-16
4. Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 98-105
5. Zavaglia C, Airoldi A, Pinzello G. Antiviral therapy of HBV- and HCV-induced liver cirrhosis. J Clin Gastroenterol 2000; 30: 234-241
6. Kim JW, Lee HS, Woo GH, Yoon JH, Jang JJ, Chi JG, Kim CY. Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. Clin Infect Dis 2001; 33: 403-405
7. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567-572
8. Lu LG, Zeng MD, Mao YM, Li JQ, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX, Zhang HQ. Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial. World J Gastroenterol 2003; 9: 2480-2483
9. Mao YM, Zeng MD, Lu LG, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX, Zhang HQ. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol 2004; 10: 3269-3273
10. Cheng Y, Ping J, Xu HD, Fu HJ, Zhou ZH. The inhibitory effect of oxymatrine-baicailin compound on hepatitis B viral antigens secretion in HepG2.2.2.15 cells. Zhongguo Yaolixue Tongbao 2006; 22: 257-261
11. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005-1009
12. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000; 41: 882-893
13. Zhou ZH, Cheng Y, Xu HD, Fu HJ, Ping J, inventors; Shanghai Kairuisi Biotechnological Co. Ltd., assignee. A drug-compound comprising oxymatrine and baicalin. China National Invention Patent Application No. 200510029111.6, 2005 Aug 26
14. Cheng Y, Wu X, Weng X, Liu C, Li H, Zhang Q. The fluctuation of cytokine mRNA expression level of a novel T-cell-mediated immune hepatic fibrosis model in Balb/c mice. Zhonghua Chuanranbing Zazhi 2002; 20: 21-25
15. Cheng Y, Dharancy S, Malapel M, Desreumaux P. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. World I Gastroenterol 2005; 11: 7591-7596
16. Gish RG. Current treatment and future directions in the management of chronic hepatitis B viral infection. Clin Liver Dis 2005; 9: 541-565, v
17. Dong Y, Xi H, Yu Y, Wang Q, Jiang K, Li L. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol 2002; 17: 1299-1306
18. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
19. Cheng Y, Ping J, Liu C, Tan Y, Chen G. Study on effects of extracts from Salvia Miltiorrhiza and Curcuma Longa in inhibiting phosphorylated extracellular signal regulated kinase expression in rat's hepatic stellate cells. Chin J Integr Med 2006; 12(3): 1-5
20. Shi GF, Li Q. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol 2005; 11: 268-271
21. Wu CS, Piao XX, Piao DM, Jin YR, Li CH. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. World J Gastroenterol 2005; 11: 122-126
22. Xiang X, Wang G, Cai X, Li Y. Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. Chin Med J (Engl) 2002; 115: 593-596
23. Zhu XH, Qiu YD, Shen H, Shi MK, Ding YT. Effect of matrine on Kupffer cell activation in cold ischemia reperfusion injury of rat liver. World J Gastroenterol 2002; 8: 1112-1116
24. Romero MR, Efferth T, Serrano MA, Castano B, Macias RI, Briz O, Marin JJ. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Res 2005; 68: 75-83
25. Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun 2000; 276: 534-538
26. Wu JA, Attele AS, Zhang L, Yuan CS. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 2001; 29: 69-81
27. Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, Cheng VC, Tsui WH, Hung IF, Lee TS, Guan Y, Peiris JS, Yuen KY. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004; 31: 69-75
28. Jang SI, Kim HJ, Hwang KM, Jekal SJ, Pae HO, Choi BM, Yun YG, Kwon TO, Chung HT, Kim YC. Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 2003; 25: 585-594
29. Chen X, Nishida H, Konishi T. Baicalin promoted the repair of DNA single strand breakage caused by H2O2 in cultured NIH3T3 fibroblasts. Biol Pharm Bull 2003; 26: 282-284
30. Shimizu I. Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets Infect Disord 2001; 1: 227-240
31. Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 2000; 15 Suppl: D84-90
32. Friedman SL, Bansal MB. Reversal of hepatic fibrosis - fact or fantasy? Hepatology 2006; 43: S82-88